Complete the information below to download the infographic on DIR fees, and to request a consultation with our drug information experts.
The original intent of DIR fees was to pass rebate savings from PBMs to Medicare. However, DIR fees have found their way into Commercial network arrangements and have been adversely affecting profit margins of retail pharmacies.
Having the right tools to understand the impact DIR fees have on the pharmacy business – along with measuring loss files and calculating generic effective rates (GERs) based on acquisition cost – is vital to sustained growth and profitability.
Predictive Acquisition Cost (PAC) is a pricing solution that tracks a more accurate drug acquisition cost and helps to manage the impact of DIR fees. PAC provides an easier way to understand how DIR fees are affecting your bottom-line performance and allows you to take actions that benefit pharmacy operations.
Elsevier – The Drug Price Leader – exclusively delivers the most current and complete drug pricing and analysis tools through TRUE Daily Updates™. Elsevier records drug product, pricing and clinical updates every day, including weekends and holidays, to ensure drug information is available on the effective date — helping to keep you informed as new drugs hit the market.